The Amyloidosis Channel is supported with funding from Prothena (Silver).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2020 | Management of AL amyloidosis: measurement modalities, transplantation & CAR-T
Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, discusses the different techniques used in the management of immunoglobulin light chain (AL) amyloidosis, including assays, stem cell transplantation and CAR T-cells. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
